In a later study, we demonstrated Ca2+/CaM-activated c-Src in vitro, in human epidermoid carcinoma and breast adenocarcinoma cells, a process that was also inhibited by a CaM antagonist [43]. Here, SRC is linked to breast adenocarcinoma.